ALIVUS LIFE SCIENCES
Quarterly Results Analysis [Mar2025]
ALIVUS LIFE SCIENCES Quarterly Results
Standalone | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹650 Cr | ₹642 Cr | ₹507 Cr | ₹589 Cr | ₹537 Cr | ₹573 Cr | ₹595 Cr | ₹578 Cr |
Expenses | ₹451 Cr | ₹452 Cr | ₹373 Cr | ₹429 Cr | ₹395 Cr | ₹400 Cr | ₹428 Cr | ₹385 Cr |
Operating Income | ₹198 Cr | ₹190 Cr | ₹134 Cr | ₹159 Cr | ₹141 Cr | ₹173 Cr | ₹167 Cr | ₹193 Cr |
Other Income | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹2 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Profit Before Tax | ₹191 Cr | ₹185 Cr | ₹127 Cr | ₹150 Cr | ₹130 Cr | ₹161 Cr | ₹159 Cr | ₹182 Cr |
Profit After Tax | ₹142 Cr | ₹137 Cr | ₹95 Cr | ₹111 Cr | ₹98 Cr | ₹119 Cr | ₹119 Cr | ₹135 Cr |
EPS | ₹11.58 | ₹11.18 | ₹7.78 | ₹9.10 | ₹7.99 | ₹9.69 | ₹9.69 | ₹11.05 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALIVUS LIFE SCIENCES | -2.4% | -9.5% | 18% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -3.5% | 9.2% |
DIVIS LABORATORIES | -2.8% | 1.3% | 42.3% |
CIPLA | -0.3% | 3% | -2.6% |
TORRENT PHARMACEUTICALS | -1% | -0.5% | 13.2% |
DR REDDYS LABORATORIES | -3.7% | 7.2% | 8.2% |
MANKIND PHARMA | -1.4% | -7.7% | 5% |
ZYDUS LIFESCIENCES | -2.1% | 8.5% | -12.1% |
LUPIN | -3.4% | -0.6% | 21.1% |
ALIVUS LIFE SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.20 % |
Y-o-Y | 21.05 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹650 Cr | 1.20 | |
Dec2024 | ₹642 Cr | 26.63 | |
Sep2024 | ₹507 Cr | -13.89 | |
Jun2024 | ₹589 Cr | 9.69 | |
Mar2024 | ₹537 Cr | -6.32 | |
Dec2023 | ₹573 Cr | -3.79 | |
Sep2023 | ₹595 Cr | 2.92 | |
Jun2023 | ₹578 Cr | - |
ALIVUS LIFE SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 4.27 % |
Y-o-Y | 40.29 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹198 Cr | 4.27 | |
Dec2024 | ₹190 Cr | 41.64 | |
Sep2024 | ₹134 Cr | -15.75 | |
Jun2024 | ₹159 Cr | 12.75 | |
Mar2024 | ₹141 Cr | -18.03 | |
Dec2023 | ₹173 Cr | 3.27 | |
Sep2023 | ₹167 Cr | -13.50 | |
Jun2023 | ₹193 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 3.04 % |
Y-o-Y | 15.90 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 30.55% | 3.04 | |
Dec2024 | 29.65% | 11.84 | |
Sep2024 | 26.51% | -2.14 | |
Jun2024 | 27.09% | 2.77 | |
Mar2024 | 26.36% | -12.48 | |
Dec2023 | 30.12% | 7.34 | |
Sep2023 | 28.06% | -15.96 | |
Jun2023 | 33.39% | - |
ALIVUS LIFE SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 3.58 % |
Y-o-Y | 44.86 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹142 Cr | 3.58 | |
Dec2024 | ₹137 Cr | 43.69 | |
Sep2024 | ₹95 Cr | -14.50 | |
Jun2024 | ₹111 Cr | 13.83 | |
Mar2024 | ₹98 Cr | -17.54 | |
Dec2023 | ₹119 Cr | 0.02 | |
Sep2023 | ₹119 Cr | -12.34 | |
Jun2023 | ₹135 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 2.34 % |
Y-o-Y | 19.67 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 21.84 % | 2.34 | |
Dec2024 | 21.34 % | 13.51 | |
Sep2024 | 18.8 % | -0.74 | |
Jun2024 | 18.94 % | 3.78 | |
Mar2024 | 18.25 % | -11.96 | |
Dec2023 | 20.73 % | 3.96 | |
Sep2023 | 19.94 % | -14.86 | |
Jun2023 | 23.42 % | - |
ALIVUS LIFE SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 3.58 % |
Y-o-Y | 44.93 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹11.58 | 3.58 | |
Dec2024 | ₹11.18 | 43.70 | |
Sep2024 | ₹7.78 | -14.51 | |
Jun2024 | ₹9.1 | 13.89 | |
Mar2024 | ₹7.99 | -17.54 | |
Dec2023 | ₹9.69 | 0.00 | |
Sep2023 | ₹9.69 | -12.31 | |
Jun2023 | ₹11.05 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD